RajaramNagarajanMDMS
Pediatric Hematology & Oncology • Houston, TXProfessor Medical Director for Pediatric Oncology
Dr. Nagarajan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1102 Bates Ave
Houston, TX 77030
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1998 - 2002
Virginia Commonwealth University Health SystemResidency, Pediatrics, 1995 - 1998
MCP-Hahnemann College of MedicineClass of 1995
Certifications & Licensure
IN State Medical License 2021 - 2025
TX State Medical License 2023 - 2025
KY State Medical License 2021 - 2024
OH State Medical License 2006 - 2024
NC State Medical License 2020 - 2022
VA State Medical License 1997 - 2008
MN State Medical License 1999 - 2007- American Board of Pediatrics Pediatric Hematology-Oncology
- Join now to see all
Publications & Presentations
PubMed
- 106 citationsFunction and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: the Childhood Cancer Survivor StudyRajaram Nagarajan, Denis R. Clohisy, Joseph P. Neglia, Yutaka Yasui, Pauline Mitby
British Journal of Cancer. 2004-11-29 - 46 citationsPilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumorsLars M. Wagner, Brian Turpin, Rajaram Nagarajan, Brian Weiss, Timothy P. Cripe
Pediatric Blood & Cancer. 2013-09-01 - 41 citationsSecond solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.Robert E. Goldsby, Cynthia Burke, Rajaram Nagarajan, Tianni Zhou, Zhengjia Chen
Cancer. 2008-11-01
Journal Articles
- Risk of Solid Subsequent Malignant Neoplasms After Childhood Hodgkin Lymphoma–Identification of High‐Risk Populations to Guide Surveillance: A Report from the Late Eff...David Tishler, Anna T Meadows, Joseph P Neglia, Kimberley Dilley, Rajaram Nagarajan, Laura T Martin, Lisa R Diller, Cancer
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
